fMLP-Induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony- stimulating factor

Journal of Experimental and Clinical Cancer Research

Volumn 16, Issue 3, 1997, Pages 301-308

  Carulli, G ^a,b   Azzara A ^a   Minnucci, S ^a   Angiolini, C ^a   Sbrana, S ^a   Ambrogi, F ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

CD11b; Neutrophils; Non Hodgkin's lymphomas; RhG CSF

Indexed keywords

BOVINE SERUM ALBUMIN; CD11B ANTIGEN; CD18 ANTIGEN; CHEMOTACTIC FACTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LUMINOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTIGENS, CD18; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOMA, HIGH-GRADE; LYMPHOMA, INTERMEDIATE-GRADE; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; RECOMBINANT PROTEINS; STIMULATION, CHEMICAL; UP-REGULATION;

EID: 0030722938     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lieschke G.J., Burgess A.W.: Granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor (two parts). N. Engl. J. Med. 327: 28-35; 99-106; 1992 .
2. Kerst J.M., de Haas M., van der Schoot C.E., et al.: Recombinant granulocyte colony-stimulating factors administration in healthy volunteers: induction of immunophenotypicatty and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 82: 3265-3272, 1993 .
3. Spiekermann K., Emmendoerffer A., Elsner J., et al.: O Attered surface marker expression and function of G-CSF-induced neutrophils from test subjects and patients under chemotherapy. Br. J. Haematol. 87: 31-38, 1994 .
4. Carulli G., Minnucci S., Azzarà A., et al.: Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-related functions. Haematologica 80: 150-15 4, 1995 .
5. Ohsaka A., Saionij K., Sato N., Mori T., Ishimoto K, Inamatsu T.: Granulocyte colonystimulating factor down-regulates the surface expression of the human leukocyte adhesion molecule 1 on human neutrophils in vitro and in vivo. Br. J. Haemalol. 84: 574-580, 1993.
6. Ohsaka A., Kitagawa S., Sakamoto S., et al.: In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant Lymphoma. Blood 74: 2743-2748, 1989.
7. Hughes B.J., Hollers J.C., Crocket-Torabi E., Smith C.W.: Recruitment of CD1 lb/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J. Clin. Invest. 90: 1687-1696, 1992 .
8. Weston B., Todd F.R.III, Axtell R., et al.: Severe congenital neutropenia: clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. J. Lab. Clin. Med. 117: 282-290, 1991.
9. McCawley L.J., Korchak H.M., Douglas S.D., et al.: In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in Glycogen Storage Disease Type IB: granulocyte colonystimulating factor corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. Pediat. Res. 35: 84-90, 1994
10. Brugiatelli M., Federico M., Gobbi P.G., et al.: Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentricrandomizedtrial. Haematologica 78: 306-312, 1993.
11. Carulli G., Minnucci S., Gianfaldoni M.L., Angiolini C., Azzarà A., Ambrogi F.: Interactions between platelets and neutrophils in essential thrombocythemia. Effects on neutrophil chemiluminescence and superoxide anion generation. Eur. J. Clin. Invest. 25: 929-934, 1995.
12. Ricevuti G., Mazzone A., Pasoti D., Fossati G., Mazzucchelli I., Notario A.: The role of integrins in granulocyte dysfunction in myelodysplastic syndrome. Leuk. Res. 609-619, 1993 .
13. Finn A., Rebuck N.: Measurement of adhesion molecule expression on neutrophils and fixation. J. Immunol. Meth. 171: 267-268, 1994.
14. Carulli G., Gianfaldoni M.L., Azzarà A., et al.: FcRIII (CD16) expression on neutrophils from chronic myeloid leukemia. A flow cytometric study. Leuk .Res. 16: 1203-1209, 1992
15. Young I.T.: Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J. Histochem. Cytochem. 25: 935-941, 1977.
16. Carulli G., Gianfaldoni M.L., Minnucci S., et al.: FcR III (CD16) ontogeny in human myeloid cells. A flow cytometry study on circulating cells from chronic myeloid leukemia: preliminary results. J. Exp. Clin .Cancer Res 12: 219-224, 1993.
17. Berger M., O'Shea J., Cross A.S., et al.: Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J. Clin. Invest. 74: 1566-1571, 1984.
18. Petrequin P.R., Todd R.F.III, Devall R.J., Boxer L.A., Curnutte J.T.III.: Association between gelatinase release and increased plasma membrane expression of the MO1 glycoprotein. Blood 69: 605-609, 1987.
19. Smith C.W., Marlin S.D., Rothlein R., Toman C., Anderson D.C.: Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83: 2008-2017, 1989 .
20. Smith C.W., Rothlein R., Hughes B.J., Mariscalco M.M., Schmalstieg F.C., Anderson D.C.: Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelialmigration. J. Clin. Invest. 82: 1746-1756, 1988.
21. Furie M.B., Tancinco M.C.A., Smith C.W.: Monoclonal antibodies to leukocyte integrins CD1 lalCD18 and CD1 lb/CD18 or intercellular adhesion molecule-1 (ICAM-1) inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 78: 2089-2097, 1991.
22. de Haas M., Kerst J.M., van der Schoot C.E., er al.: Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 84: 3885-3894, 1994 .
23. Bronchud M.H., Potter M.R., Morgenstern G., et al.: In vitro and in vivo analysis of the effects of recombinant human granulocyte colony stimulating factor in patients. Br. J. Cancer. 58: 64-69, 1988.
24. Carulli G.: Recombinant human granulocyte colony-stimulating factor and neutrophil phenotype. Br. J. Haematol. 1995: 91: 511-520.
25. Iacobini M., Palumbo G., Bartolozzi S., et al.: Superoxide production in children with malignant tumors treated with recombinant human granulocyte colony-stimulating factor. Haematologica 80: 13-17, 1995.
26. Roesler J., Emmendorffer A., Elsner J., Zeidler C., Lohmann-Matthes M.L, Welte K.: In vitro functions of neutrophils induced by treatment with rhG-CSF in severe congenital neutropenia. Eur. J. Haematol. 46: 112-118, 1991 .
27. Elsner J., Roesler J., Emmendoerffer A., Zeidler C., Lohmann-Matthes M.L., Welte K.: Altered function and surface marker expression of neutrophils induced by rhG-CSF treatment in severe congenital neutropenia. Eur. J. Haematol. 48: 10-19, 1992.
28. Azzarà A., Carulli G., Rizzuti-Gullaci A., Minnucci S., Capochiani E., Ambrogi F.: Motility of rhG-CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis. Br. J. Haematol. 92: 161-168, 1996.
29. Yuo A., Kitagawa S., Ohsaka A., et al: Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74: 2144-2149, 1989.
30. Price T.H., Chatta G.S., Dale D.C.: Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88: 335-340, 1996.